Exelixis reported $289.08M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 119.6M 23.54M
Agios Pharmaceuticals AGIO:US $ 45.79M 14.03M
Akebia Therapeutics AKBA:US $ 253.91M 2.58M
Amgen AMGN:US $ 12886M 702M
AstraZeneca AZN:LN 22740M 146M
Bayer BAYN:GR € 31019M 1616M
Biomarin Pharmaceutical BMRN:US $ 490.42M 49.4M
Bluebird Bio BLUE:US $ 142.89M 10.1M
Bristol Myers Squibb BMY:US $ 22821M 953M
Cytokinetics CYTK:US $ 66.85M 5.01M
Eisai 4523:JP Y 313333M 8340M
Eli Lilly And LLY:US $ 13386M 1666.7M
Esperion Therapeutics ESPR:US $ 79.08M 5.73M
Exelixis EXEL:US $ 289.08M 48.51M
Genmab GEN:DC DK 1339M 229M
Glaxosmithkline GSK:US $ 24278M 608M
Immunogen IMGN:US $ 84.12M 16.83M
IONIS PHARMACEUT IONS:US $ 228.45M 12.1M
Macrogenics MGNX:US $ 67.1M 7.48M
Merk MRK:US $ 22316M 1556M
Mirati Therapeutics MRTX:US $ 123.57M 20.09M
Moderna Inc MRNA:US 9.24B 110M
Nektar Therapeutics NKTR:US $ 105.28M 20.08M
Neurocrine Biosciences NBIX:US $ 253.5M 7.7M
Novartis NOVN:VX SF 29807M 401M
Pfizer PFE:US $ 39268M 3403M
Puma Biotechnology PBYI:US $ 74.79M 34.8M
Seattle Genetics SGEN:US $ 531.29M 37.56M
Takeda 4502:JP Y 2145730M 336476M
Ultragenyx Pharmaceutical RARE:US $ 167.23M 14.14M
Xencor XNCR:US $ 60.94M 9.8M
YTE INCY:US $ 886.16M 31.86M